Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Indian Journal of Surgical Oncology|December 10, 2020
A Feasibility Study of Sentinel Lymph Node Biopsy in Endometrial Cancer Using Technetium 99m NanocolloidVidhyalakshmi S, Anirudhan, Latha Balasubramani
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2025
Awareness about Cervical Cancer and Acceptance of Pap Smear for Screening among Women Attending a Tertiary Care CenterAishwarya Sudhager, Nandini Vallath, Rahul Krishnatry, et al.
Gynecologic Oncology|September 12, 2009
The detection of cervical intraepithelial neoplasia by electrical impedance spectroscopy: the effects of acetic acid and tissue homogeneityLatha Balasubramani, Brian H Brown, Jamie Healey, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 22, 2026
AOGIN India Policy Statement on the Use of HPV Vaccination for Cervical Cancer EliminationLatha Balasubramani, Bhagyalaxmi Nayak, Nisha Singh, et al.
Journal of Robotic Surgery|September 18, 2016
Differences in hand movements and task completion times between laparoscopic, robotically assisted, and open surgery: an in vitro studyLatha Balasubramani, David A Milliken, John H Shepherd, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2024
Out-reach Colposcopy Clinics and HPV Self-Sampling Decreases Loss to Follow up in a Community based Cervical Cancer Screening ProgrammeP Thasneem, Aishwarya Sudhager, C Nalini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesisJanet E Flatley, Kristelle McNeir, Latha Balasubramani, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2023
Cervical Cancer Screening Coverage at Tertiary Care Institutes Across IndiaRakhi Rai, Rohini Sehgal, Seema Singhal, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Bulletin of the World Health Organization|May 9, 2025
National Cancer Grid initiative for electronic medical records, IndiaC S Pramesh, Rizwan Koita, Manju Sengar, et al.
Pageof 1